Received Jul 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENACTRA) | SANOFI PASTEUR | UNK | — | OT |
he had a rash the next day after the vaccine was administered; Initial information received on 09-Jul-2025 regarding an unsolicited valid non-serious case received from a physician. This case is linked to this case US-SA-2025SA194402 This case involves a 18 years old male patient who was administered with Meningococcal A-C-Y-W135 (D Conj) Vaccine [Menactra] and had rash the next day. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date In 2019, the patient received an unknown dose of suspect Meningococcal A-C-Y-W135 (D Conj) Vaccine, Solution for injection, Strength:standard (lot number, strength and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination. Information on the batch number was requested corresponding to the one at time of event occurrence On an unknown date In 2019 the patient had a rash the next day after the vaccine was administered (rash) (unknown latency). Reportedly,The patient's mother claims there was a reaction to MENACTRA in 2019, and since then she didn't give the booster. Now, her child's school is requesting the booster shot, is it a contraindication to give MENQUADFI the patient's mother called them 4 days after the vaccine was administered and claimed that he had a rash the next day after injection. He didn't have anaphylaxis, didn't have shortness of breath, and didn't go to the emergency room. Parent gave Benadryl and the rash lasted 4 days after injection. The physician confirmed that it was MENACTRA to which the patient had a reaction Action taken was not applicable. The patient was treated with DIPHENHYDRAMINE (BENADRYL [DIPHENHYDRAMINE]) for Rash. At time of reporting, the outcome was Unknown for the event he had a rash the next day after the vaccine was administered.; Sender's Comments: US-SA-2025SA194402: